Osteopenia refers to lower-than-normal bone density that is not severe enough to be classified as osteoporosis. It is often identified through bone density screening and may represent an early stage of bone los…
Osteopenia refers to lower-than-normal bone density that is not severe enough to be classified as osteoporosis. It is often identified through bone density screening and may represent an early stage of bone loss. While osteopenia does not always progress, it can increase the risk of future bone weakening if left unaddressed.
Early evaluation provides an opportunity to implement strategies that may help preserve bone strength over time.
Osteopenia is a condition in which bone mineral density is reduced compared to normal levels but not to the extent seen in osteoporosis. It reflects an imbalance between bone formation and bone loss.
Osteopenia itself does not usually cause symptoms, but it signals an increased risk for further bone loss.
Osteopenia typically does not cause noticeable symptoms. In some cases, individuals may experience:
Symptoms usually arise only if bone loss progresses.
Osteopenia may develop due to several factors, including:
Identifying contributing factors helps guide prevention strategies.
Diagnosis is based primarily on bone density testing and may include:
Regular monitoring helps track changes in bone density.
Treatment focuses on slowing bone loss and supporting bone health. Options may include:
Management is individualized based on overall risk.
A rheumatology evaluation may be helpful if you have:
Specialized care can help guide appropriate monitoring.
Our approach emphasizes early identification, individualized risk assessment, and preventive strategies to support long-term bone health. Monitoring allows timely adjustments to care plans.
Advanced therapies are considered when fracture risk increases.
If you have been diagnosed with osteopenia or have concerns about bone health, scheduling a consultation can help clarify your risk and explore management options.